Lifevantage Corporation (LFVN) to Issue Quarterly Dividend of $0.05 on December 15th

Lifevantage Corporation (NASDAQ:LFVN) declared a quarterly dividend on Friday, October 31st. Shareholders of record on Monday, December 1st will be paid a dividend of 0.045 per share on Monday, December 15th. This represents a c) dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Monday, December 1st.

Lifevantage has a dividend payout ratio of 16.7% indicating that its dividend is sufficiently covered by earnings.

Lifevantage Stock Up 1.4%

NASDAQ:LFVN opened at $6.86 on Friday. The business’s 50-day moving average price is $8.21 and its two-hundred day moving average price is $11.18. Lifevantage has a twelve month low of $5.98 and a twelve month high of $27.38. The stock has a market cap of $87.07 million, a P/E ratio of 9.26 and a beta of 0.22.

Lifevantage (NASDAQ:LFVN) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.17 by $0.01. The company had revenue of $47.56 million during the quarter, compared to analyst estimates of $54.74 million. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%. Lifevantage has set its FY 2026 guidance at 1.000-1.150 EPS.

Insider Buying and Selling at Lifevantage

In other news, Director Michael A. Beindorff sold 12,607 shares of the company’s stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $6.42, for a total value of $80,936.94. Following the completion of the sale, the director owned 43,806 shares of the company’s stock, valued at approximately $281,234.52. This represents a 22.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have sold 52,932 shares of company stock valued at $379,927. Insiders own 21.95% of the company’s stock.

Hedge Funds Weigh In On Lifevantage

A number of large investors have recently added to or reduced their stakes in the business. Capital Management Corp VA boosted its position in Lifevantage by 63.0% during the third quarter. Capital Management Corp VA now owns 2,064,176 shares of the company’s stock valued at $20,084,000 after buying an additional 798,066 shares during the period. Driehaus Capital Management LLC purchased a new position in shares of Lifevantage in the first quarter worth about $6,701,000. Geode Capital Management LLC lifted its stake in shares of Lifevantage by 106.1% in the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock valued at $3,210,000 after acquiring an additional 126,274 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in shares of Lifevantage by 393,513.8% in the 1st quarter. Russell Investments Group Ltd. now owns 114,148 shares of the company’s stock valued at $1,664,000 after acquiring an additional 114,119 shares during the last quarter. Finally, Trexquant Investment LP purchased a new stake in Lifevantage during the 1st quarter valued at about $1,607,000. Hedge funds and other institutional investors own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.